|
Name |
Eremofortin F
|
| Molecular Formula | C26H38O6 | |
| IUPAC Name* |
[(1R,2R,7S,8aS)-8a-(hydroxymethyl)-1-methyl-6-oxo-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydronaphthalen-2-yl] (4E,6E)-3,9-dihydroxy-2-methyldeca-4,6-dienoate
|
|
| SMILES |
C[C@H]1[C@@H](CCC2=CC(=O)[C@@H](C[C@]12CO)C(=C)C)OC(=O)C(C)C(/C=C/C=C/CC(C)O)O
|
|
| InChI |
InChI=1S/C26H38O6/c1-16(2)21-14-26(15-27)19(5)24(12-11-20(26)13-23(21)30)32-25(31)18(4)22(29)10-8-6-7-9-17(3)28/h6-8,10,13,17-19,21-22,24,27-29H,1,9,11-12,14-15H2,2-5H3/b7-6+,10-8+/t17?,18?,19-,21-,22?,24+,26-/m0/s1
|
|
| InChIKey |
LSVIDWGNANJIBB-BFBLSFCDSA-N
|
|
| Synonyms |
Eremofortin F
|
|
| CAS | NA | |
| PubChem CID | 139585727 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 446.6 | ALogp: | 3.2 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 104.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 32 | QED Weighted: | 0.28 |
| Caco-2 Permeability: | -4.543 | MDCK Permeability: | 0.00001080 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.993 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.033 |
| Blood-Brain-Barrier Penetration (BBB): | 0.538 | Plasma Protein Binding (PPB): | 77.75% |
| Volume Distribution (VD): | 0.331 | Fu: | 13.99% |
| CYP1A2-inhibitor: | 0.199 | CYP1A2-substrate: | 0.405 |
| CYP2C19-inhibitor: | 0.104 | CYP2C19-substrate: | 0.879 |
| CYP2C9-inhibitor: | 0.03 | CYP2C9-substrate: | 0.93 |
| CYP2D6-inhibitor: | 0.327 | CYP2D6-substrate: | 0.667 |
| CYP3A4-inhibitor: | 0.471 | CYP3A4-substrate: | 0.521 |
| Clearance (CL): | 5.142 | Half-life (T1/2): | 0.491 |
| hERG Blockers: | 0.03 | Human Hepatotoxicity (H-HT): | 0.319 |
| Drug-inuced Liver Injury (DILI): | 0.122 | AMES Toxicity: | 0.208 |
| Rat Oral Acute Toxicity: | 0.221 | Maximum Recommended Daily Dose: | 0.338 |
| Skin Sensitization: | 0.17 | Carcinogencity: | 0.708 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
| Respiratory Toxicity: | 0.946 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004127 | ![]() |
0.670 | D07DVK | ![]() |
0.229 | ||
| ENC004660 | ![]() |
0.657 | D0IT2G | ![]() |
0.229 | ||
| ENC003895 | ![]() |
0.625 | D0CW1P | ![]() |
0.229 | ||
| ENC004128 | ![]() |
0.513 | D02RQU | ![]() |
0.228 | ||
| ENC002230 | ![]() |
0.437 | D03SXE | ![]() |
0.228 | ||
| ENC001526 | ![]() |
0.365 | D0CZ1Q | ![]() |
0.223 | ||
| ENC002137 | ![]() |
0.346 | D0D1SG | ![]() |
0.217 | ||
| ENC003292 | ![]() |
0.336 | D0KR5B | ![]() |
0.217 | ||
| ENC003294 | ![]() |
0.324 | D0R7JT | ![]() |
0.214 | ||
| ENC003293 | ![]() |
0.321 | D0D2TN | ![]() |
0.214 | ||